/connect-gujarat-english/media/media_files/2025/12/29/untitled-2025-12-29-14-28-45.png)
/connect-gujarat-english/media/post_banners/7e5575c752d3082979cf695c1ccfbd697c6e72c1aaebccf0bca3c04ba24c4b01.webp)
Pfizer halts trial for twice a day weight loss drug
The reason for its decision was the high rates of adverse events such as nausea, vomiting, and diarrhoea leading to nearly half the participants discontinuing the medication
/connect-gujarat-english/media/post_banners/8bec1b704413bb11b860937d7fae5cf99bd775c153162d0e49b9b73d90854547.webp)
US FDA halts Sun Pharma's trials on dermatological drug
The company said it would work closely with the US FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next 30 days
/connect-gujarat-english/media/post_banners/bfe474698ca28e26f947b381e21a348bddf9d06e87aa33b00676fc8ae3efddd4.webp)
/connect-gujarat-english/media/post_banners/06aeab755dd82bcd77ea1976f5d91a5bf3bc771cd13fa121027f93ece146b0bc.webp)